Configure your own data insights with our huge database of swiss startups.

ZenOwn’s solutions are already deployed across 23 brands in 31 countries. With CHF 50,000 in FIF Seed Digital funding, the company will accelerate hiring and enterprise integrations, supporting the ...

Nun hat CASUS im Rahmen einer strategischen Neuausrichtung CASUS Create an das deutsche Unternehmen LAWLIFT verkauft. Seit ...

Wyss Zurich was founded to pave the way from basic research to the market. Its ten-year track record shows that it has been ...

The second edition makes an extensive examination of Swiss start-up exits and places them in an international context. In addition, the peculiarities of the start-up scene are compared with Israel and ...

The end of the year is always hectic in the start-up scene. But the numerous news items in recent weeks could also point to a slow end to the funding crisis.

KA-EX, a patented dietary supplement developed to boost recovery after intensive sports, is today a mainstream product in the sports industry. More than 1000 professional athletes, European sports ...

Investing in private markets can be difficult and time-consuming. Available options typically demand high investment minimums, capital calls, long-term fund commitments of 10-12 years, opaque ...

With the Start-up innovation project, Innosuisse directly funds high potential science-based projects initiated by Swiss start-ups, giving them a financial boost to propel their market entry. The ...

ONWARD Medical successfully raised an amount of EUR 50 million in gross proceeds by way of an upsized bookbuild offering through a private placement with institutional investors. Ottobock, a global ...

MassChallenge Switzerland, part of MassChallenge’s global network for innovators and zero-equity startup accelerators, just awarded CHF 500,000 in equity-free cash prizes and in-kind awards to the top ...

Based in Allschwil (Baselland), GlioCART is developing a new type of cell therapy – the first CAR-T cell therapy – designed to target both glioblastoma tumors and the surrounding immune-suppressive ...